ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Commercialized
Register Number
07387014
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jul 23, 2012
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number07387014
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
TACROLIMUSActive
Quantity: 0,5 mg
Name: TACROLIMUS
ATC CLASSIFICATION (3)
L04A
L04AD
L04AD02